Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |